These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 18443271

  • 1. The effect of azacitidine on interleukin-6 signaling and nuclear factor-kappaB activation and its in vitro and in vivo activity against multiple myeloma.
    Khong T, Sharkey J, Spencer A.
    Haematologica; 2008 Jun; 93(6):860-9. PubMed ID: 18443271
    [Abstract] [Full Text] [Related]

  • 2. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
    Romagnoli M, Desplanques G, Maïga S, Legouill S, Dreano M, Bataille R, Barillé-Nion S.
    Clin Cancer Res; 2007 Oct 15; 13(20):6010-8. PubMed ID: 17947462
    [Abstract] [Full Text] [Related]

  • 3. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
    Hideshima T, Neri P, Tassone P, Yasui H, Ishitsuka K, Raje N, Chauhan D, Podar K, Mitsiades C, Dang L, Munshi N, Richardson P, Schenkein D, Anderson KC.
    Clin Cancer Res; 2006 Oct 01; 12(19):5887-94. PubMed ID: 17020997
    [Abstract] [Full Text] [Related]

  • 4. Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity.
    Thyrell L, Arulampalam V, Hjortsberg L, Farnebo M, Grandér D, Pokrovskaja Tamm K.
    Exp Cell Res; 2007 Nov 15; 313(19):4015-24. PubMed ID: 17880940
    [Abstract] [Full Text] [Related]

  • 5. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
    Yasui H, Hideshima T, Raje N, Roccaro AM, Shiraishi N, Kumar S, Hamasaki M, Ishitsuka K, Tai YT, Podar K, Catley L, Mitsiades CS, Richardson PG, Albert R, Brinkmann V, Chauhan D, Anderson KC.
    Cancer Res; 2005 Aug 15; 65(16):7478-84. PubMed ID: 16103102
    [Abstract] [Full Text] [Related]

  • 6. Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature.
    Olivier S, Close P, Castermans E, de Leval L, Tabruyn S, Chariot A, Malaise M, Merville MP, Bours V, Franchimont N.
    Mol Pharmacol; 2006 May 15; 69(5):1615-23. PubMed ID: 16497877
    [Abstract] [Full Text] [Related]

  • 7. Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.
    Park J, Ahn KS, Bae EK, Kim BS, Kim BK, Lee YY, Yoon SS.
    Anticancer Drugs; 2008 Sep 15; 19(8):777-82. PubMed ID: 18690088
    [Abstract] [Full Text] [Related]

  • 8. Genistein down-regulates the constitutive activation of nuclear factor-kappaB in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis.
    He H, Chen L, Zhai M, Chen JZ.
    Phytother Res; 2009 Jun 15; 23(6):868-73. PubMed ID: 19107739
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myeloma.
    Voorhees PM, Chen Q, Kuhn DJ, Small GW, Hunsucker SA, Strader JS, Corringham RE, Zaki MH, Nemeth JA, Orlowski RZ.
    Clin Cancer Res; 2007 Nov 01; 13(21):6469-78. PubMed ID: 17975159
    [Abstract] [Full Text] [Related]

  • 10. OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms.
    Zhang S, Suvannasankha A, Crean CD, White VL, Johnson A, Chen CS, Farag SS.
    Clin Cancer Res; 2007 Aug 15; 13(16):4750-8. PubMed ID: 17699852
    [Abstract] [Full Text] [Related]

  • 11. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo.
    Hsu YL, Kuo PL, Tzeng TF, Sung SC, Yen MH, Lin LT, Lin CC.
    J Gastroenterol Hepatol; 2008 Jul 15; 23(7 Pt 2):e290-9. PubMed ID: 18522681
    [Abstract] [Full Text] [Related]

  • 12. The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-κB activity.
    Nakaya A, Sagawa M, Muto A, Uchida H, Ikeda Y, Kizaki M.
    Leuk Res; 2011 Feb 15; 35(2):243-9. PubMed ID: 20542334
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
    Tassone P, Neri P, Burger R, Savino R, Shammas M, Catley L, Podar K, Chauhan D, Masciari S, Gozzini A, Tagliaferri P, Venuta S, Munshi NC, Anderson KC.
    Clin Cancer Res; 2005 Jun 01; 11(11):4251-8. PubMed ID: 15930364
    [Abstract] [Full Text] [Related]

  • 14. Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells.
    Bauer K, Kretzschmar AK, Cvijic H, Blumert C, Löffler D, Brocke-Heidrich K, Schiene-Fischer C, Fischer G, Sinz A, Clevenger CV, Horn F.
    Oncogene; 2009 Aug 06; 28(31):2784-95. PubMed ID: 19503092
    [Abstract] [Full Text] [Related]

  • 15. Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor.
    Sanda T, Iida S, Ogura H, Asamitsu K, Murata T, Bacon KB, Ueda R, Okamoto T.
    Clin Cancer Res; 2005 Mar 01; 11(5):1974-82. PubMed ID: 15756023
    [Abstract] [Full Text] [Related]

  • 16. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT, Li XF, Breitkreutz I, Song W, Neri P, Catley L, Podar K, Hideshima T, Chauhan D, Raje N, Schlossman R, Richardson P, Munshi NC, Anderson KC.
    Cancer Res; 2006 Jul 01; 66(13):6675-82. PubMed ID: 16818641
    [Abstract] [Full Text] [Related]

  • 17. Antimyeloma effects of a sesquiterpene lactone parthenolide.
    Suvannasankha A, Crean CD, Shanmugam R, Farag SS, Abonour R, Boswell HS, Nakshatri H.
    Clin Cancer Res; 2008 Mar 15; 14(6):1814-22. PubMed ID: 18347184
    [Abstract] [Full Text] [Related]

  • 18. BCL-XL regulates TNF-alpha-mediated cell death independently of NF-kappaB, FLIP and IAPs.
    Gozzelino R, Sole C, Llecha N, Segura MF, Moubarak RS, Iglesias-Guimarais V, Perez-Garcia MJ, Reix S, Zhang J, Badiola N, Sanchis D, Rodriguez-Alvarez J, Trullas R, Yuste VJ, Comella JX.
    Cell Res; 2008 Oct 15; 18(10):1020-36. PubMed ID: 18591962
    [Abstract] [Full Text] [Related]

  • 19. The synthetic triterpenoid CDDO-Imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cells.
    Liby K, Voong N, Williams CR, Risingsong R, Royce DB, Honda T, Gribble GW, Sporn MB, Letterio JJ.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4288-93. PubMed ID: 16857804
    [Abstract] [Full Text] [Related]

  • 20. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells.
    Kim H, Chung H, Kim HJ, Lee JY, Oh MY, Kim Y, Kong G.
    Breast Cancer Res Treat; 2008 Nov 15; 112(2):287-96. PubMed ID: 18158619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.